HRR: molecular mechanisms of pulmonary disease Flashcards

1
Q

What is the inheritance pattern of CF?

A

Autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Briefly describe CF.

A

A multisystem disease that results in a buildup of mucus in the lungs, pancreas, and other organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe CF’s impact in the pancreas.

A

The mucus prevents digestive enzyme release, causing an inability to break down food and absorb nutrients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe CF’s impact in the lungs.

A

Thick mucus clogs the airways and keeps bacteria trapped.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What secondary conditions can CF put you at risk for?

A

Liver disease, osteoporosis, male infertility, pancreatitis, bowel obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who should be offered carrier screenings?

A

All pregnant people or people planning a pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is CFTR?

A

A chloride channel that establishes a driving force for sodium transport, and water as a result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is CFTR’s significance in CF?

A

CF occurs when CFTR is absent or abnormal, resulting in abnormal ion transport that leads to a less watery, thick mucus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most dangerous CFTR mutation?

A

Class I, which results in no synthesis of CFTR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common CFTR mutation?

A

Class II, which results in abnormal production of CFTR. This causes the cell to not recognize the protein and not express it on the cell surface.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is involved in the daily care of CF?

A

Airway clearance, nutrition, and infection control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can be used for airway clearance in CF?

A

Percussion to loosen mucus, bronchodilators to dilate airways, inhaled antibiotics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What medication can be used for CF? How does it work?

A

Ivacaftor; it allows defective CFTR channels to open and let chloride ions pass.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who should get genetic testing for CF?

A

Parents of a CF child who want another child, someone with CF having a family, siblings of CF, partners of known carriers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the main organs impacted by A1AT deficiency?

A

Lungs and liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does A1AT do?

A

Binds neutrophil elastase to prevent breakdown of elastase; without it, elastin in the lungs is eaten away.

17
Q

A1AT deficiency increases risk for what condition in adults? In children?

A

COPD in adults, liver diseases in children and adults.

18
Q

Where is A1AT made?

A

Made in liver and sent into circulation.

19
Q

What liver diseases occur in A1AT deficiency?

A

Cirrhosis, fibrosis, hepatocellular carcinoma.

20
Q

How common is A1AT deficiency?

A

Fairly rare, but it’s very underdiagnosed.

21
Q

What is the gene associated with A1AT?

A

SERPINA1.

22
Q

What is the normal A1AT genotype?

A

MM.

23
Q

What is the allelic expression of A1AT genes?

A

Codominant.

24
Q

What is the inheritance pattern of A1AT deficiency?

A

Autosomal recessive.

25
Q

What is the common mutation in A1AT?

A

Z.

26
Q

Describe the effect of a ZZ A1AT mutation on the liver.

A

About ¼ of infants will have detectable abnormalities, with about 5% being at risk for clinically significant disease. Liver issues can appear early in life, go away, and then return in adulthood.

27
Q

Describe the S variant in A1AT deficiency.

A

A variant that isn’t usually associated with liver disease.

28
Q

Describe the F variant in A1AT.

A

It produces a normal A1AT level, but it is dysfunctional. It does not bind neutrophil elastase properly. Lung risks but not much liver risk.

29
Q

Describe the I variant in A1AT.

A

Causes moderate A1AT deficiency and isn’t known to accumulate in the liver.

30
Q

How many testing methods are recommended for diagnosis of A1AT deficiency?

A

2.

31
Q

What are general tests ordered when considering A1AT treatment?

A

Chest CT, spirometry, liver screening.

32
Q

What are treatment options for A1AT deficiency?

A

COPD therapies (oxygen, pulm rehab, bronchodilators, corticosteroids, etc), lifestyle modification, organ transplant as a last option.

33
Q

What is augmentation therapy?

A

Weekly infusion of human serum A1AT from healthy donors. This increases A1AT to correct deficiency. This can slow lung function decline and emphysema progression.